• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Opinion

Video

Educating Patients on Systemic Prurigo Nodularis Treatment and Adherence

TJ Chao, MPAS, PA-C, discusses how to approach conversations with patients about starting systemic therapy for prurigo nodularis, emphasizing the importance of setting realistic treatment expectations, promoting long-term adherence, and providing tips for managing biologic agents administered on a bimonthly or monthly basis.

Video Player is loading.
Current Time 0:00
Duration 3:50
Loaded: 0%
Stream Type LIVE
Remaining Time 3:50
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Video content above is prompted by the following:

    • How do you approach the conversation with patients when starting a systemic agent?
    • How do you set treatment expectations to ensure adherence to systemic therapy, and what kind of tips can you share about long-term goals of treatment?
    • Provide ways to promote adherence with these biologic agents as they are given on a bi-monthly or monthly basis.

    © 2025 MJH Life Sciences

    All rights reserved.